Literature DB >> 20975239

[Study of setup margins in radiation therapy: how many verification times and patients are required].

Mitsuhiro Matsumoto1, Seiichi Ohta, Yoshimi Ohno, Yuji Ogata.   

Abstract

INTRODUCTION: The purpose of this research is to require suitable numbers of verification times and patients for calculating the setup margin (SM) in radiotherapy.
METHODS: 1) This simulation was performed using the standard normal distribution random number. The simulation used the seven levels of verification from 5 to 35 in 5 steps, and 35 patients. 2) The setup error in prostate radiotherapy at three hospitals was analyzed. Systematic error and random error were calculated from each patient's average value and standard deviation. Furthermore, we used the formula of J Stroom to calculate SM. Suitable numbers of verification times and patients were obtained from statistical analysis of the simulated results.
RESULTS: 1) In the results of our simulations using random number, SM converged on 1.0 to 1.3 mm, regardless of the number of patients, when there were more than 15 verification times; 2) The results of clinical data were slightly different from the standard normal distribution, and more than 15 verification times and over 15 patients were required.
CONCLUSIONS: In conclusion, calculation of the SM in radiotherapy required more than 15 verification times and over 15 patients.

Entities:  

Mesh:

Year:  2010        PMID: 20975239     DOI: 10.6009/jjrt.66.1186

Source DB:  PubMed          Journal:  Nihon Hoshasen Gijutsu Gakkai Zasshi        ISSN: 0369-4305


  2 in total

Review 1.  Target margins in radiotherapy of prostate cancer.

Authors:  Slav Yartsev; Glenn Bauman
Journal:  Br J Radiol       Date:  2016-07-20       Impact factor: 3.039

2.  Retrospective analysis of the impact of respiratory motion in treatment margins for frameless lung SBRT based on respiratory-correlated CBCT data-sets.

Authors:  Sheeba Thengumpallil; Damien Racine; Jean-François Germond; Nicolas Péguret; Jean Bourhis; François Bochud; Raphaël Moeckli
Journal:  J Appl Clin Med Phys       Date:  2020-09-30       Impact factor: 2.102

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.